Market Place
Sourcing Support
All News #Library
Generics
Slow Inbrija launch forces Acorda to slash $800M sales hopes
14 Feb 2020 //
FIERCE PHARMA
Novartis Corp. v. West-Ward Pharmaceuticals Int`l (Fed. Cir. 2019)
17 May 2019 //
PATENTDOCS
Cialis (tadalafil) : Eli Lilly vs. Qilu Pharm Co., Ltd.
20 Dec 2018 //
PATENT LITIGATION
Bendamustine Hydrochloride Injection : Eagle Pharmaceuticals vs. Slayback Pharma
22 Sep 2018 //
PATENT LITIGATION
FDA sets back review date of Acorda’s levodopa inhaler for Parkinson’s disease
14 Sep 2018 //
FIERCE BIOTECH
U.S. appeals court invalidates Acorda patents on MS drug
11 Sep 2018 //
CNBC
Acorda inks Ampyra generic pacts as Ampyra appeal pends
06 Aug 2018 //
FIERCE PHARMA
Acorda loses bid for U.S. court order halting generic Ampyra sales
26 Jul 2018 //
REUTERS
CEO: Win or lose on Ampyra, Acorda`s reps are safe with Inbrija
06 Jun 2018 //
FIERCE PHARMA
Acorda Asks Fed. Circ. To Undo Nix Of Ampyra Drug Patents
11 Aug 2017 //
LAW360
Acorda Therapeutics investor calls for company to explore sale
08 Aug 2017 //
REUTERS
Court nixes Acorda patents, teeing up Ampyra generics and potential cost cuts
03 Apr 2017 //
FIERCE PHARMA
Pharma`s new patent worry by the numbers: No `IP death squad` here, analyst says
04 Sep 2015 //
FIERCE PHARMA
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.